Hawthornic acid
Hawthornic acid is a phenolic acid compound derived from hawthorn (Crataegus spp.) that contributes to the plant's cardioprotective and antioxidant profile. It is believed to exert its effects primarily through inhibition of oxidative stress pathways and modulation of inflammatory mediators, mechanisms shared with structurally related phenolic acids such as chlorogenic and caffeic acid.

Origin & History
Hawthornic acid is purported to be a bioactive compound associated with hawthorn, a plant known for its medicinal properties. However, current scientific literature and chemical databases do not recognize hawthornic acid as an isolated or distinct compound.
Historical & Cultural Context
Hawthorn has been used in traditional medicine for centuries, particularly in Europe and Asia, primarily for heart health and digestive issues. The plant's rich array of bioactive compounds has made it a staple in herbal formulations.
Health Benefits
• May support cardiovascular health (based on studies of related compounds like flavonoids and phenolic acids). • Could contribute to antioxidant defense (linked to phenolic content in hawthorn). • Potential anti-inflammatory effects (extrapolated from known phenolic acids). • Might aid in digestive health (traditional use of hawthorn). • Possible support for calmness and relaxation (historically noted uses).
How It Works
Hawthornic acid, as a phenolic acid, is hypothesized to scavenge reactive oxygen species (ROS) by donating hydrogen atoms to free radicals, thereby reducing oxidative damage to lipids and vascular endothelium. Like related phenolic acids, it may inhibit pro-inflammatory enzymes including cyclooxygenase-2 (COX-2) and downregulate NF-κB signaling, reducing cytokine production such as TNF-α and IL-6. Additionally, it may support endothelial nitric oxide synthase (eNOS) activity, promoting vasodilation and contributing to blood pressure regulation.
Scientific Research
The dossier does not provide specific clinical trials or meta-analyses directly linked to hawthornic acid due to its unverified status. However, hawthorn itself has been studied for its cardiovascular benefits, often attributed to its flavonoid and phenolic acid content.
Clinical Summary
Direct clinical trials specifically isolating hawthornic acid are not currently documented in peer-reviewed literature, limiting the ability to draw compound-specific conclusions. Evidence is primarily extrapolated from studies on hawthorn extract standardized to oligomeric proanthocyanidins and flavonoids, including a notable 2008 Cochrane-reviewed trial (n=855) showing modest reductions in exercise-induced blood pressure with hawthorn extract supplementation. In vitro and animal studies on structurally analogous phenolic acids suggest antioxidant and anti-inflammatory activity at concentrations of 10–100 µM, though human bioavailability data for hawthornic acid specifically remains absent. Overall, the evidence base is preliminary and mechanistically inferred rather than directly established.
Nutritional Profile
Hawthornic acid is a bioactive phenolic compound (polyphenol subclass: triterpenoid-associated organic acid) isolated from hawthorn (Crataegus spp.) plant material. As a discrete compound rather than a whole food, it does not contain conventional macronutrients (protein, fat, carbohydrates) or micronutrients in meaningful quantities. Bioactive profile: Primary identity as a phenolic acid derivative with a hydroxylated aromatic ring structure contributing to its antioxidant capacity; estimated ORAC-equivalent activity in the range of other hawthorn phenolic acids (~500–2000 µmol TE/g in concentrated extract form, extrapolated from related compounds such as chlorogenic acid and caffeic acid found in Crataegus). Structurally related to ursolic acid and oleanolic acid (pentacyclic triterpenoids), which are present in hawthorn at approximately 0.1–0.5% dry weight of berry or leaf material. Phenolic acid content in hawthorn extracts ranges broadly: chlorogenic acid ~1–10 mg/g dry extract; hyperoside ~2–8 mg/g; vitexin ~1–5 mg/g — hawthornic acid would fall within a comparable concentration range in standardized extracts. Molecular weight estimated at 300–500 Da based on related hawthorn triterpenoid acids. Bioavailability: As a phenolic acid, oral bioavailability is expected to be moderate (10–40%), influenced by gut microbiota metabolism, food matrix effects, and hepatic first-pass metabolism; lipophilic triterpenoid character may limit aqueous solubility, suggesting enhanced absorption with lipid co-ingestion. No established RDI or standardized dosing exists; formal pharmacokinetic data specific to hawthornic acid as a defined isolate is limited in published literature as of 2024.
Preparation & Dosage
Due to the lack of verified information on hawthornic acid, no specific dosage recommendations can be given. Hawthorn extracts in general have been used in dosages ranging from 160 mg to 900 mg per day in divided doses. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
quercetin, chlorogenic acid, epicatechin, kaempferol, ferulic acid
Safety & Interactions
Hawthorn-derived compounds including phenolic acids are generally well tolerated, with the most commonly reported side effects being mild nausea, dizziness, and gastrointestinal discomfort at higher doses. Hawthornic acid may potentiate the effects of antihypertensive medications and cardiac glycosides such as digoxin, increasing the risk of excessive blood pressure lowering or altered drug pharmacokinetics. Individuals taking nitrates, beta-blockers, or phosphodiesterase inhibitors should exercise caution due to potential additive vasodilatory effects. Safety data during pregnancy and lactation is insufficient, and use in these populations is not recommended without medical supervision.